Quest Diagnostics rises after Q1 beat, upbeat annual forecast

Quest Diagnostics

21/04/2026 18:23

Updates

** Shares of laboratory operator Quest Diagnostics DGX.N rise 4% to $203.51 in afternoon trading

** Co reports Q1 adjusted profit of $2.50 per share, vs. analysts’ average estimate of $2.35 per share - LSEG data

** Posts Q1 revenue of $2.90 billion, vs. estimates of $2.83 billion

** Raises FY 2026 adjusted EPS forecast to $10.63 to $10.83, vs. IBES estimate of about $10.55

** Leerink Partners analyst Michael Cherny says underlying growth remains strong, with higher testing volumes and better revenue per test supporting margins despite mix headwinds

** Including session's moves, DGX up ~13% YTD

(Reporting by Sahil Pandey in Bengaluru)

((Sahil.Pandey@thomsonreuters.com))